| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 5,250 | 5,330 | 26.09. | |
| 5,230 | 5,280 | 25.09. |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 11.09. | Implantica's Capital Markets Day webcast available on demand | 391 | PR Newswire | VADUZ, Liechtenstein, Sept. 11, 2026 /PRNewswire/ -- Implantica AG (publ.) would like to thank all who attended its Capital Markets Day in Stockholm on September 9, 2026.
A recording of the... ► Artikel lesen | |
| 08.09. | Implantica to host Capital Markets Day in Stockholm on September 9 | 11 | Cision News | ||
| 25.08. | Implantica to host Capital Markets Day in Stockholm on September 9 | 531 | PR Newswire | VADUZ, Liechtenstein, Aug. 25, 2026 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including the innovative RefluxStop... ► Artikel lesen | |
| 21.08. | Implantica: Umsatz steigt um 66 % - FDA-Zulassung beflügelt Ausblick | 4 | Investing.com Deutsch | ||
| 21.08. | Implantica: Umsatz steigt um 66 % - FDA-Zulassung beflügelt US-Wachstumsaussichten | 7 | Investing.com Deutsch | ||
| IMPLANTICA Aktie jetzt für 0€ handeln | |||||
| 21.08. | Implantica AG Q2 Loss Declines | 4 | RTTNews | ||
| 21.08. | Implantica publishes Interim Report January - June 2026 (Q2) | 561 | PR Newswire | VADUZ, Liechtenstein, Aug. 21, 2026 /PRNewswire/ -- FDA Approval of RefluxStop - Strategic Preparation Sets the Stage for Success
Significant events in the second quarter of 2026RefluxStop... ► Artikel lesen | |
| 21.08. | Implantica erhält FDA-Zulassung für Reflux-Implantat RefluxStop | 6 | Investing.com Deutsch | ||
| 21.08. | Implantica receives FDA approval for GERD implant RefluxStop | 4 | Investing.com | ||
| 21.08. | Implantica receives FDA approval for RefluxStop - Opening the U.S. market | 643 | PR Newswire | VADUZ, Liechtenstein, Aug. 21, 2026 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, announced today that the U.S.... ► Artikel lesen | |
| 14.08. | Implantica presents the second quarter (Q2 2026) on August 21 at 15:00 CEST | 4 | Cision News | ||
| 10.06. | Implantica AG: Bulletin from the Annual General Meeting of Implantica AG | 225 | GlobeNewswire (Europe) | Today, June 10, 2026, the annual general meeting (the "AGM") of Implantica AG (publ) was held in Ruggell, Liechtenstein. The general meeting resolved to adopt all of the board of directors' resolution... ► Artikel lesen | |
| 09.06. | Implantica announces launch of 20th RefluxStop Center of Excellence in Spain, part of a world-renowned US hospital group | 413 | PR Newswire | VADUZ, Liechtenstein, June 9, 2026 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including the innovative RefluxStop... ► Artikel lesen | |
| 22.05. | Implantica publishes Interim Report January - March 2026 (Q1) | 603 | PR Newswire | VADUZ, Liechtenstein, May 22, 2026 /PRNewswire/ --
Substantially Advancing Clinical Outcomes & Economic Impact of RefluxStopSignificant events in the first quarter of 2026Secured over... ► Artikel lesen | |
| 21.05. | Notice of Annual General Meeting of Implantica AG | 448 | PR Newswire | VADUZ, Liechtenstein, May 21, 2026 /PRNewswire/ -- The depository receipt holders of Implantica AG, reg. no. FL-0002.629.889-3, are hereby invited to attend the annual general meeting to... ► Artikel lesen | |
| 21.05. | Implantica announces publication of a new health economics study showing RefluxStop's superior cost-effectiveness in the treatment of GERD in the Italian Healthcare System | 8 | Cision News | ||
| 20.05. | Implantica submits final response to FDA in the PMA application for RefluxStop for U.S. market approval | 1.252 | PR Newswire | VADUZ, Liechtenstein, May 20, 2026 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including... ► Artikel lesen | |
| 19.05. | Implantica announces new breakthrough long-term RefluxStop data on severe sufferers presented at DDW 2026 | 952 | PR Newswire | VADUZ, Liechtenstein, May 19, 2026 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including the innovative RefluxStop... ► Artikel lesen | |
| 19.05. | IMPLANTICA: RefluxStop gains momentum at DDW 2026 | 2 | Cision News | ||
| 18.05. | Implantica presents the first quarter (Q1 2026) on May 22 at 15:00 CET | 336 | PR Newswire | VADUZ, Liechtenstein, May 18, 2026 /PRNewswire/ -- Implantica AG (publ) invites investors to a presentation of the first quarter 2026 at 15:00 CET on May 22. The interim report for the first... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 46,150 | +0,91 % | Fresenius baut Kapazität in Europa für 54 Mio Euro aus | DJ Fresenius baut Kapazität in Europa für 54 Mio Euro aus
DOW JONES--Fresenius hat seine Kapazitäten für die Herstellung von Infusionslösungen in Polen und Italien erweitert. Wie der DAX-Konzern... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 39,800 | +1,14 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 37,790 | +1,56 % | Buy or Goodbye?: Meta, Novo Nordisk, SAP & Siemens Healthineers - Die Analystenstimmen des Tages | © Foto: Uwe Anspach/dpaMeta, Novo Nordisk, SAP, Siemens Healthineers: Die wichtigsten Analysten-Updates im Überblick Enthaltene Werte: DE0007164600,US30303M1027,DE000SHL1006,DK0062498333Den vollständigen... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 31,060 | -1,52 % | EQS-PVR: Carl Zeiss Meditec AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution | EQS Voting Rights Announcement: Carl Zeiss Meditec AG
Carl Zeiss Meditec AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the... ► Artikel lesen | |
| ECKERT & ZIEGLER | 12,170 | 0,00 % | EQS-PVR: Eckert & Ziegler SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution | EQS Voting Rights Announcement: Eckert & Ziegler SE
Eckert & Ziegler SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective... ► Artikel lesen | |
| INTUITIVE SURGICAL | 356,50 | +0,32 % | 1.156 Trades im Juli: Das sind Trumps Aktien-Zocks: Millionenverkäufe bei zwei Tech-Riesen | © Foto: Julia Demaree Nikhinson - APIn Trumps Depot wurden im Juli 1.156 Transaktionen verzeichnet, darunter Verkäufe von Microsoft- und Amazon-Aktien für jeweils bis zu 25 Millionen US-Dollar sowie... ► Artikel lesen | |
| UNITEDHEALTH | 331,80 | +0,36 % | UnitedHealth Group creates new chief administrative officer position | ||
| DRAEGERWERK | 122,60 | +0,49 % | Drägerwerk-Aktie // Dicker Freudensprung | Bei Drägerwerk läuft das Geschäft weiterhin sehr gut. Dies belegen überzeugende Zahlen für das erste Halbjahr. So erhöhte sich der Umsatz um 6,2 Prozent auf rund 1,6 Milliarden Euro. Bereinigt wäre... ► Artikel lesen | |
| MEDTRONIC | 77,44 | -0,44 % | Dividendenbekanntmachungen (25.09.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ADF GROUP INC CA00089N1033 0,02 CAD 0,0124 EUR ALERUS FINANCIAL CORPORATION US01446U1034 0,22 USD 0,1933 EUR ASMODEE GROUP AB SE0023615638 - 0... ► Artikel lesen | |
| GERRESHEIMER | 26,040 | -0,53 % | Warum Gerresheimer jetzt auf jeder Watchlist stehen sollte - die stille Story | ||
| THERMO FISHER | 589,80 | -0,41 % | Biodesix meldet Fortschritte bei MRD-Testprogrammen mit Bio-Rad und Thermo Fisher | ||
| TELADOC HEALTH | 5,376 | +0,67 % | Teladoc Health, Inc.: Teladoc Health Announces Chief Legal Officer Transition | NEW YORK, Sept. 25, 2026 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, today announced a leadership transition in its legal function. After 11 years with... ► Artikel lesen | |
| STRATEC | 22,800 | +0,88 % | EQS-PVR: STRATEC SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution | EQS Voting Rights Announcement: STRATEC SE
STRATEC SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 8,215 | +0,06 % | Alignment Healthcare Reports Second Quarter 2026 Results, Surpassing High End of Guidance Across All Key Metrics | Generates $1.3 billion in total revenue, representing 31.6% growth year-over-year Grows Medicare Advantage membership 31.5% year-over-year to approximately 294,100 membersRaises the midpoint of all... ► Artikel lesen | |
| AVEANNA HEALTHCARE | 12,410 | 0,00 % | Biotech Stocks At 52-Week Highs - Park Dental Partners +10%, Aveanna Healthcare +24%, Candel Therapeutics +10% on Q2 Reports, Labcorp Holdings, Hemab Therapeutics | LONDON (dpa-AFX) - The following biotech stocks reached 52-week highs on August 13, 2026, driven by key catalysts such as positive quarterly reports and the issuance of increased guidance figures.Park... ► Artikel lesen |